Acumentis Quote - ACU

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.079

Bid

0.076

Offer

0.079

Volume

460,491

0.074 Day's Range 0.079

0.064 52 Week Range 0.095

Market Cap

17.236M

Previous Close

0.079

Open

0.076

Last Trade

7332

0.079

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

71,708

Shares Outstanding

218,174,605

Dividend Yield

PE Ratio

12.31

Earnings Per Share (EPS)

0.01

Revenue

57.18M

Net Profit

1.43M

Sector

Real Estate Agents & Mgrs

Industry

Real Estate Agents & Mgrs

Website

www.lmw.com.au

Headquarters

Sydney, New South Wales, Aus

Founded

Acumentis Group Limited is listed in the Real Estate Agents & Mgrs sector of the Australian Stock Exchange with ticker ACU. The last closing price for Acumentis was AUD0.08. Over the last year, Acumentis shares have traded in a share price range of AUD 0.064 to AUD 0.095.

Acumentis currently has 218,174,605 shares in issue. The market capitalisation of Acumentis is AUD17.24 million. Acumentis has a price to earnings ratio (PE ratio) of 12.31.

Avantogen and Hawaii Biotech Combine Vaccine Businesses; World-Class Vaccine Developer is Created to Accelerate Pandemic Influe

Avantogen Limited (Avantogen)(ASX:ACU), and Hawaii Biotech, Inc. (Hawaii Biotech), a privately held company, closed today on the Definitive...

Avantogen and Hawaii Biotech to Combine Vaccine Businesses; New Vaccine Pure-Play, 50%-50% Owned, to Expand Research in Hawaii

Avantogen Limited (Avantogen) (ASX:ACU), and Hawaii Biotech, Inc. (Hawaii Biotech), a privately held company, today announced that they have...

Avantogen's Proprietary Adjuvant, GPI-0100, to Be Presented to International Vaccine Meeting; Structure-Activity Relations of Im

Avantogen (ASX:ACU) today announced the acceptance of a scientific paper entitled, "Synergistic Effects of Immune Agonists on Efficacy of...

Avantogen's Vaccine Adjuvant GPI-0100 Licensed by Hawaii Biotech Inc.; GPI-0100 Is Licensed Initially for West Nile Virus and De

Avantogen Limited, (formerly Australian Cancer Technology Limited "AustCancer")(ASX:ACU), and Hawaii Biotech, Inc. (HawaiiBio) today announced...

Avantogen Receives Milestone Payment from Endocyte for GPI Vaccine Adjuvant; Company Also Receives European Patent and Commences

Avantogen, Ltd. (ASX:ACU), formerly Australian Cancer Technology, today announced that Endocyte, Inc. will pay its first milestone payment to the...

Australian Cancer Technology Changes Name to Avantogen; With a Robust Pipeline Including Late-Stage Cancer Products and Powerful

Australian Cancer Technology, Ltd. (ASX:ACU) announced today that the Company's name has changed to Avantogen Limited, by a vote of shareholders...

Webcast Alert: ACU Presentation at AMEX IR Alliance Small Cap Investor Conference

Webcast Alert: ACU Presentation at AMEX IR Alliance Small Cap Investor Conference FAIRFIELD, Conn., Dec. 1 /PRNewswire-FirstCall/ -- What:...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0.079	0	0	0	DE
4	-0.014	-15.0537634409	0.093	0.093	0.074	86170	0.0926373	DE
12	0.001	1.28205128205	0.078	0.095	0.074	71708	0.08980554	DE
26	-0.002	-2.46913580247	0.081	0.095	0.073	119012	0.08268979	DE
52	0.008	11.2676056338	0.071	0.095	0.064	137891	0.07685605	DE
156	-0.061	-43.5714285714	0.14	0.145	0.046	112835	0.08008082	DE
260	-0.051	-39.2307692308	0.13	0.185	0.046	126276	0.09710844	DE

ACU - Frequently Asked Questions (FAQ)

What is the current Acumentis share price?

The current share price of Acumentis is AUD 0.079

How many Acumentis shares are in issue?

Acumentis has 218,174,605 shares in issue

What is the market cap of Acumentis?

The market capitalisation of Acumentis is AUD 17.24M

What is the 1 year trading range for Acumentis share price?

Acumentis has traded in the range of AUD 0.064 to AUD 0.095 during the past year

What is the PE ratio of Acumentis?

The price to earnings ratio of Acumentis is 12.31

What is the cash to sales ratio of Acumentis?

The cash to sales ratio of Acumentis is 0.31

What is the reporting currency for Acumentis?

Acumentis reports financial results in AUD

What is the latest annual turnover for Acumentis?

The latest annual turnover of Acumentis is AUD 57.18M

What is the latest annual profit for Acumentis?

The latest annual profit of Acumentis is AUD 1.43M

What is the registered address of Acumentis?

The registered address for Acumentis is LEVEL 7, 283 CLARENCE STREET, SYDNEY, NEW SOUTH WALES, 2000

What is the Acumentis website address?

The website address for Acumentis is www.lmw.com.au

Which industry sector does Acumentis operate in?

Acumentis operates in the REAL ESTATE AGENTS & MGRS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
JAYJayride Group Limited	AUD 0.003 (50.00%)	200k
EGNEngenco Ltd	AUD 0.29 (38.10%)	1.47M
NUCNuchev Limited	AUD 0.20 (37.93%)	138.99k
IRXInhaleRx Ltd	AUD 0.037 (37.04%)	438.57k
SPAOSpacetalk Ltd	AUD 0.05 (35.14%)	55k
M2MOMT Malcolm Mines NL	AUD 0.003 (-50.00%)	141k
ERGEneco Refresh Limited	AUD 0.009 (-35.71%)	2.16M
FFFOForbidden Foods Limited	AUD 0.002 (-33.33%)	1.5M
FAUFirst AU Limited	AUD 0.002 (-33.33%)	6.57M
HTMOHighTech Metals Ltd	AUD 0.035 (-28.57%)	62.5k
AVEOAAvecho Biotechnology Limited	AUD 0.001 (0.00%)	83.47M
ROGRed Sky Energy Limited	AUD 0.006 (0.00%)	45.11M
SYASayona Mining Limited	AUD 0.02 (0.00%)	44.71M
VAUVault Minerals Ltd	AUD 0.4125 (-0.60%)	39.89M
TLSTelstra Corporation Limited	AUD 4.17 (-0.12%)	21.88M